Creating Tomorrow's Diagnostics
and Treatments

Learn more

Faculty by Area of Research

The discoveries made in the laboratories at National Jewish Health have a profound impact on the understanding and treatment of human disease, with an emphasis on respiratory, immune and related diseases.

Search by Name, Specialty, Program, or Research.


Bioanalytical & Central Laboratory Services for Research


National Jewish Health Advanced Diagnostic Laboratories is a high-complexity, CLIA-certified laboratory with more than 50 years’ experience developing assays and performing preclinical and clinical testing. Learn more.

Tucker Medical Library

Quality information for healthcare, education and scientific research. Learn more.

 

Technology Transfer

Targeting CYP11A1 in the Steroidogenic Pathway For Treating Allergic Diseases
Dr. Gelfand’s laboratory has identified CYP11A1 as a key regulator of allergic responses through its effect on steroidogenesis. Inhibition of CYP11A1 with aminoglutethimide in an animal model of either asthma or peanut allergy prevented an allergic response and the accumulation of inflammatory cells in a dose dependent manner. The therapeutic approach seen in asthma and peanut allergy could be applicable to other allergic diseases.

Technology Transfer Office

Research Administration and Support

National Jewish Health supports academic and research activities across the campus and at outside organizations, including the University of Colorado Denver. Learn more.

 

Clinical Trials

We conduct clinical trials for patients with asthma, allergy, COPD, eczema, ILD, cystic fibrosis and more. Search All Clinical Trials.

 

Weinberg Clinical Research Unit

The Weinberg Clinical Research Unit focuses primarily on respiratory conditions. We entered the 21st century as the only institution in the world dedicated exclusively to this research of allergy, asthma, COPD/emphysema and sleep disorders as well as immune and autoimmune conditions, such as rheumatoid arthritis and cystic fibrosis. Learn more.


Bookmark and Share

Recent Publications

Motivational enhancement to improve adherence to positive airway pressure in patients with obstructive sleep apnea: a randomized controlled trial. PubMed

γδ T cells recognize the insulin B:9-23 peptide antigen when it is dimerized through thiol oxidation. PubMed

More publications.

 

Do you have idiopathic pulmonary fibrosis?

National Jewish Health researchers are conducting a clinical trial to determine the efficacy and safety of an investigational medication for the treatment of idiopathic pulmonary fibrosis. You may be eligible to participate if you are between the ages of 40 and 90 years old and you have had a diagnosis of idiopathic pulmonary fibrosis for less than six years. Qualified study participants receive study drug or placebo, pulmonary testing and financial compensation. Call a study coordinator directly at 303.398.1708 to find out more.